Next |
home / stock / dtil / dtil message board
Subject | By | Source | When |
---|---|---|---|
bulls and bears | jondoeuk | investorshub | 06/20/2023 11:13:21 AM |
$DTIL The trading | carusso | investorshub | 06/16/2023 11:12:52 AM |
$DTIL Price now | swampboots | investorshub | 06/15/2023 10:03:08 PM |
The trading up | jondoeuk | investorshub | 06/12/2023 11:00:11 PM |
$DTIL bulls and bears | jondoeuk | investorshub | 06/12/2023 4:35:07 AM |
Price trading up | NY1972 | investorshub | 06/11/2023 10:46:11 AM |
MomentumIts trading | swampboots | investorshub | 06/11/2023 1:29:34 AM |
$DTIL The now last up | jondoeuk | investorshub | 06/10/2023 6:32:43 AM |
Price gaining up | NY1972 | investorshub | 06/10/2023 6:15:48 AM |
$DTIL short squeeze article | jondoeuk | investorshub | 06/08/2023 3:37:25 PM |
Price now last trade up | rtrstock | investorshub | 06/06/2023 4:35:17 AM |
The poster https://tunetx.com/wp-content/uploads/2023/05/TuneTx-ASGCT-2023 CAR-T | jondoeuk | investorshub | 06/03/2023 5:20:40 PM |
PR https://www.businesswire.com/news/home/20230531005625/en/Precision-BioScience | jondoeuk | investorshub | 05/31/2023 6:49:15 PM |
$DTIL .77 and this this morning: | swampboots | investorshub | 05/31/2023 6:20:16 PM |
MomentumIts now last trade up | jondoeuk | investorshub | 05/31/2023 8:01:26 AM |
$DTIL The gaining | rtrstock | investorshub | 05/30/2023 6:36:27 PM |
From FB https://www.fiercebiotech.com/research/precision-biosciences-boasts-prec | jondoeuk | investorshub | 05/26/2023 9:55:42 PM |
The company will provide an update on its | jondoeuk | investorshub | 05/26/2023 9:55:07 PM |
$DTIL got some short data | jondoeuk | investorshub | 05/25/2023 1:22:35 PM |
$DTIL The trading | rtrstock | investorshub | 05/24/2023 9:04:26 PM |
News, Short Squeeze, Breakout and More Instantly...
Precision BioSciences Inc. Company Name:
DTIL Stock Symbol:
NYSE Market:
Precision BioSciences Inc. Website:
Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today announced its addition to the Russel...
Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, is presenting data today at the United Mit...
Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today announced the appointment of Mark Su...